Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 3Fallopian Tube Neoplasms 3Advanced Ovarian Cancer 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Pain, Postoperative 2Vomiting 1Thromboembolism 1Primary Peritoneal Neoplasm 1Postoperative Hemorrhage 1Peritoneal Neoplasms 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Neoplasm Metastasis 1Myofibroma 1Disease Progression 1Carcinoma, Ovarian Epithelial 1Blood Loss, Surgical 1

Interventions

tumor necrosis factor-alpha, CNGRC fusion protein, human 2liposomal doxorubicin 2Doxorubicin 2niraparib 1copanlisib 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Lidocaine 1Gemcitabine 1Conservative Treatment 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Saline Solution × Gynecologic × Clear all
NCT05560035 2022-09-29

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

General Hospital of Ningxia Medical University

Phase NA Unknown
60 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡